Sanofi is team­ing with Ver­i­ly on a $500M JV aimed at mar­ry­ing tech with di­a­betes drugs

A year af­ter the phar­ma gi­ant Sanofi $SNY agreed to col­lab­o­rate with Ver­i­ly Life Sci­ences (for­mer­ly Google Life Sci­ences) to spawn a new tech plat­form for man­ag­ing di­a­betes, the glob­al com­pa­nies are fol­low­ing up by es­tab­lish­ing a new joint ven­ture that will be tasked with ac­com­plish­ing the alpine goals they’ve set out for them­selves.

Based in Kendall Square — ground ze­ro in the glob­al biotech hub in Cam­bridge, MA — the new On­duo will be led by Joshua Riff, a vet­er­an of the U.S. man­aged care world, where dis­ease man­age­ment has be­come a core fo­cus for some of the coun­try’s biggest in­sur­ers.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.